Nutex Health (NUTX) Receivables - Other (2016 - 2023)

Nutex Health has disclosed Receivables - Other across 5 years of filings, most recently posting $538259.0 for Q1 2023.

• Receivables - Other for Q1 2023 came in at $538259.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2023 was $538259.0 (changed N/A YoY), and the FY2022 annual result was $538184.0, down 58.23% from the prior year.
• Receivables - Other came in at $538259.0 for Q1 2023 at Nutex Health, roughly flat from $538184.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $6.7 million in Q3 2021 to a low of $538184.0 in Q4 2022.
• The 3-year median for Receivables - Other is $1.3 million (2021), against an average of $2.0 million.
• Peak annual rise in Receivables - Other reached 58.23% in 2022, while the deepest fall reached 74.7% in 2022.
• Nutex Health's Receivables - Other stood at $1.3 million in 2021, then plunged by 58.23% to $538184.0 in 2022, then advanced by 0.01% to $538259.0 in 2023.
• The last three Receivables - Other figures came in at $538259.0 (Q1 2023), $538184.0 (Q4 2022), and $1.7 million (Q3 2022), per Business Quant data.